Australia markets open in 5 hours 4 minutes

Stoke Therapeutics, Inc. (STOK)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
14.70-0.37 (-2.46%)
As of 02:54PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close15.07
Open14.88
Bid14.58 x 100
Ask14.72 x 100
Day's range14.52 - 15.26
52-week range3.35 - 17.58
Volume232,582
Avg. volume1,519,154
Market cap766.174M
Beta (5Y monthly)0.88
PE ratio (TTM)N/A
EPS (TTM)-2.42
Earnings date05 Aug 2024 - 09 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est23.50
  • Business Wire

    Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

    BEDFORD, Mass., June 18, 2024--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today announced that, effective on June 17, 2024, the company granted stock options to purchase an aggregate of 10,400 shares of common stock to one new employee, as a material inducement to their employment in accordance with Nasdaq Listing Rule 5635(c)(4).

  • Simply Wall St.

    We Think Stoke Therapeutics (NASDAQ:STOK) Can Afford To Drive Business Growth

    Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

  • Business Wire

    Stoke Therapeutics to Present at Upcoming Investor Conferences in June

    BEDFORD, Mass., June 03, 2024--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today announced that management will present at the following upcoming investor conferences: